Mereo BioPharma (MREO) Prepaid Assets (2017 - 2026)

Mereo BioPharma (MREO) has 10 years of Prepaid Assets data on file, last reported at $2.2 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $2.2 million, down 10.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 10.72% YoY), and the FY2025 annual result was $2.5 million, up 16.37% from the prior year.
• Prepaid Assets fell to $2.2 million in Q1 2026 per MREO's latest filing, from $2.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $5.2 million in Q4 2023 and troughed at $464000.0 in Q3 2024.
• A 5-year average of $2.5 million and a median of $2.5 million in 2025 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets plunged 57.82% in 2024, then soared 480.6% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $3.7 million in 2022, then soared by 40.67% to $5.2 million in 2023, then sank by 57.82% to $2.2 million in 2024, then rose by 16.37% to $2.5 million in 2025, then slipped by 11.14% to $2.2 million in 2026.
• Business Quant data shows MREO's Prepaid Assets at $2.2 million in Q1 2026, $2.5 million in Q4 2025, and $2.7 million in Q3 2025.